Edgewell Personal Care (EPC) Financials

$20.92 +0.09 (+0.43%)

Closing price 09/18/2025 03:59 PM Eastern

Extended Trading

$20.93 +0.01 (+0.04%)

As of 09/18/2025 07:41 PM Eastern

Annual Income Statements for Edgewell Personal Care

This table shows Edgewell Personal Care's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2014	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Net Income / (Loss) Attributable to Common Shareholders	356	-275	179	5.70	103	570	68	118	100	115	99
Consolidated Net Income / (Loss)	356	-275	179	5.70	103	-372	68	118	100	115	99
Net Income / (Loss) Continuing Operations	118	-296	179	5.70	103	570	68	118	100	115	99
Total Pre-Tax Income	146	-459	220	-53	164	-390	87	147	124	148	121
Total Operating Income	266	-199	295	-1.10	215	244	176	240	182	227	199
Total Gross Profit	1,290	1,184	1,160	1,126	1,033	967	881	951	881	941	956
Total Revenue	2,612	2,421	2,362	2,298	2,234	2,141	1,950	2,087	2,172	2,252	2,254
Operating Revenue	2,612	2,421	2,362	2,298	2,234	2,141	1,950	2,087	2,172	2,252	2,254
Total Cost of Revenue	1,322	1,237	1,202	1,173	1,202	1,174	1,069	1,136	1,291	1,311	1,298
Operating Cost of Revenue	1,322	1,237	1,202	1,173	1,202	1,174	1,069	1,136	1,291	1,311	1,298
Total Operating Expenses	1,024	1,383	865	1,127	818	351	705	711	698	714	756
Selling, General & Admin Expense	535	572	413	393	395	-	409	391	389	410	430
Marketing Expense	371	367	337	318	293	251	216	242	238	229	232
Research & Development Expense	70	71	72	68	61	54	55	58	56	59	58
Restructuring Charge	50	55	37	30	39	46	25	21	15	17	36
Total Other Income / (Expense), net	-120	-260	-75	-52	-51	-64	-89	-93	-58	-79	-78
Interest Expense	119	100	72	69	68	63	87	94	71	79	77
Other Income / (Expense), net	-0.80	-81	-3.40	17	17	-1.50	-1.30	1.20	13	-0.80	-1.90
Income Tax Expense	28	-163	41	-59	61	-18	20	29	25	33	22
Basic Earnings per Share	$5.74	($4.44)	$3.02	$0.10	$1.90	($6.88)	$1.25	$2.17	$1.87	$2.24	$1.98
Weighted Average Basic Shares Outstanding	62M	62M	59.20M	57.30M	54.40M	54.21M	54.36M	54.37M	51.44M	50.02M	48.72M
Diluted Earnings per Share	$5.69	($4.44)	$2.99	$0.10	$1.90	($6.88)	$1.24	$2.13	$1.85	$2.21	$1.97
Weighted Average Diluted Shares Outstanding	62M	62M	59.20M	57.30M	54.40M	54.21M	54.36M	54.37M	51.44M	50.02M	48.72M
Weighted Average Basic & Diluted Shares Outstanding	62M	62M	59.20M	57.30M	54.40M	54.21M	54.36M	54.37M	51.44M	50.02M	48.72M
Cash Dividends to Common per Share	$2.00	$1.50	-	-	-	-	-	-	-	$0.60	$0.60

This table shows Edgewell Personal Care's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	12	19	53	30	4.80	36	49	8.80	-2.10	29	29
Consolidated Net Income / (Loss)	12	19	53	30	4.80	36	49	8.80	-2.10	29	29
Net Income / (Loss) Continuing Operations	12	19	53	30	4.80	36	49	8.80	-2.10	29	29
Total Pre-Tax Income	17	27	71	33	6.00	47	63	5.40	-1.70	41	37
Total Operating Income	32	57	86	52	26	70	83	20	20	59	54
Total Gross Profit	190	242	280	229	198	258	287	213	192	256	269
Total Revenue	469	598	650	534	489	599	648	518	478	581	627
Operating Revenue	469	598	650	534	489	599	648	518	478	581	627
Total Cost of Revenue	280	356	370	306	291	341	361	305	287	325	359
Operating Cost of Revenue	280	356	370	306	291	341	361	305	287	325	359
Total Operating Expenses	158	186	194	177	172	188	204	192	171	197	215
Selling, General & Admin Expense	96	105	96	112	103	108	110	109	103	106	104
Marketing Expense	46	63	80	40	48	63	77	44	50	66	80
Research & Development Expense	13	14	15	16	13	14	15	16	14	14	14
Restructuring Charge	2.70	3.00	3.00	7.90	6.80	3.20	3.10	23	4.20	12	16
Total Other Income / (Expense), net	-15	-30	-15	-19	-20	-23	-20	-15	-22	-18	-17
Interest Expense	20	21	19	19	20	20	19	18	19	20	19
Other Income / (Expense), net	5.00	-9.50	3.80	-0.10	-0.30	-2.70	-1.40	2.50	-3.20	2.60	2.90
Income Tax Expense	4.60	7.20	18	3.40	1.20	11	14	-3.40	0.40	12	8.10
Basic Earnings per Share	$0.24	$0.38	$1.04	$0.58	$0.10	$0.72	$0.99	$0.17	($0.04)	$0.60	$0.62
Weighted Average Basic Shares Outstanding	51.17M	-	50.81M	50.02M	50.10M	49.80M	49.50M	48.72M	48.70M	48M	46.80M
Diluted Earnings per Share	$0.24	$0.37	$1.02	$0.58	$0.09	$0.72	$0.98	$0.18	($0.04)	$0.60	$0.62
Weighted Average Diluted Shares Outstanding	51.17M	-	50.81M	50.02M	50.50M	50.20M	50.10M	48.72M	48.70M	48.20M	47M
Weighted Average Basic & Diluted Shares Outstanding	51.17M	-	50.81M	50.02M	49.93M	49.55M	49.31M	48.72M	48.23M	47.03M	46.46M

This table details how cash moves in and out of Edgewell Personal Care's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2014	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Net Change in Cash & Equivalents	131	-417	27	-236	-237	75	23	115	-291	28	-7.30
Net Cash From Operating Activities	572	149	187	314	259	191	233	229	102	216	231
Net Cash From Continuing Operating Activities	572	149	187	314	259	191	233	229	102	216	231
Net Income / (Loss) Continuing Operations	356	-275	179	5.70	103	-372	68	118	100	115	99
Consolidated Net Income / (Loss)	356	-275	179	5.70	103	-372	68	118	100	115	99
Depreciation Expense	136	115	93	94	98	94	89	87	90	91	88
Non-Cash Adjustments To Reconcile Net Income	69	521	27	324	41	582	44	54	25	38	27
Changes in Operating Assets and Liabilities, net	11	-212	-111	-110	18	-113	33	-30	-113	-28	17
Net Cash From Investing Activities	-263	-175	-70	-85	-119	-46	-196	-49	-355	-51	-62
Net Cash From Continuing Investing Activities	-263	-175	-70	-85	-119	-46	-196	-49	-355	-51	-62
Purchase of Property, Plant & Equipment	-85	-99	-70	-69	-62	-58	-48	-57	-56	-50	-57
Acquisitions	-187	-106	0.00	-34	-90	0.00	-234	-0.30	-309	0.00	0.00
Sale of Property, Plant & Equipment	9.10	17	0.00	18	4.70	4.10	96	7.50	5.00	0.00	0.00
Other Investing Activities, net	-0.10	14	-	0.00	9.70	8.40	2.90	0.90	5.40	-1.00	-5.90
Net Cash From Financing Activities	-148	-327	-93	-478	-380	-64	-19	-65	-18	-147	-179
Net Cash From Continuing Financing Activities	-148	-327	-93	-478	-380	-64	-19	-65	-18	-147	-179
Repayment of Debt	-140	-2,168	-653	-586	-798	-509	-67	-526	-556	-872	-900
Repurchase of Common Equity	-94	-175	-197	-165	-124	0.00	0.00	-9.20	-125	-75	-59
Payment of Dividends	-124	-93	-	-	-	0.00	0.00	-26	-33	-32	-31
Issuance of Debt	194	2,604	756	273	550	440	50	500	707	841	817
Other Financing Activities, net	6.60	-500	-	-	-7.50	5.40	-2.00	-4.20	-11	-9.00	-7.30
Effect of Exchange Rate Changes	-30	-64	2.90	13	2.50	-6.10	5.60	-0.40	-20	8.60	3.50
Cash Interest Paid	120	164	71	66	67	61	56	61	68	74	63
Cash Income Taxes Paid	115	55	28	14	22	58	25	25	24	46	34

This table details how cash moves in and out of Edgewell Personal Care's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Change in Cash & Equivalents	-4.60	-29	35	27	-10	-18	-0.10	13	-34	-5.40	30
Net Cash From Operating Activities	-86	88	166	48	-73	129	101	74	-116	45	115
Net Cash From Continuing Operating Activities	-86	87	161	55	-73	129	101	74	-116	45	115
Net Income / (Loss) Continuing Operations	12	19	53	30	4.80	36	49	8.80	-2.10	29	29
Consolidated Net Income / (Loss)	12	19	53	30	4.80	36	49	8.80	-2.10	29	29
Depreciation Expense	23	23	23	23	23	22	22	21	22	22	22
Non-Cash Adjustments To Reconcile Net Income	7.20	7.10	6.60	17	7.10	6.40	7.20	6.50	7.50	6.40	6.60
Changes in Operating Assets and Liabilities, net	-128	37	79	-15	-107	64	23	37	-143	-12	57
Net Cash From Investing Activities	-11	-8.80	-12	-19	-6.00	-14	-17	-26	-16	-17	-12
Net Cash From Continuing Investing Activities	-11	-4.80	-12	-23	-7.00	-14	-17	-26	-16	-17	-12
Purchase of Property, Plant & Equipment	-11	-7.50	-12	-18	-6.50	-12	-13	-26	-17	-17	-16
Other Investing Activities, net	0.10	2.70	0.70	-4.50	-0.50	-2.20	-4.60	0.40	1.10	-0.20	3.20
Net Cash From Financing Activities	83	-112	-103	-14	70	-129	-80	-40	110	-37	-83
Net Cash From Continuing Financing Activities	83	-115	-100	-14	70	-129	-80	-40	110	-37	-83
Repayment of Debt	-127	-265	-323	-158	-126	-106	-693	-197	152	5.60	-47
Repurchase of Common Equity	-15	-15	-15	-30	-15	-15	-9.90	-18	-30	-35	-25
Payment of Dividends	-8.30	-7.80	-7.70	-7.70	-7.60	-8.20	-7.50	-7.40	-7.90	-7.30	-7.20
Issuance of Debt	241	172	237	191	220	-0.20	631	182	3.70	-0.20	-4.30
Effect of Exchange Rate Changes	10	3.60	-	-	-	-4.10	-4.20	4.90	-12	4.20	10

This table presents Edgewell Personal Care's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2014	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Total Assets	6,929	4,986	4,772	4,189	3,953	3,421	3,541	3,675	3,713	3,741	3,731
Total Current Assets	2,730	1,637	1,452	1,186	951	1,044	984	1,136	942	962	936
Cash & Equivalents	1,129	712	739	503	266	342	365	479	189	216	209
Accounts Receivable	495	280	261	224	227	206	159	151	137	106	109
Inventories, net	617	333	309	334	330	357	314	346	449	492	477
Prepaid Expenses	489	312	143	126	129	140	146	160	167	147	140
Plant, Property, & Equipment, net	752	499	486	453	424	396	371	363	346	338	349
Total Noncurrent Assets	3,447	2,851	2,833	2,549	2,578	1,981	2,186	2,176	2,425	2,440	2,446
Goodwill	1,487	1,422	1,420	1,446	1,451	1,033	1,160	1,163	1,322	1,331	1,339
Intangible Assets	1,847	1,409	1,385	1,072	1,099	913	928	906	997	974	949
Other Noncurrent Operating Assets	113	21	28	32	28	35	99	107	107	135	159
Total Liabilities & Shareholders' Equity	6,929	4,986	4,772	4,189	3,953	3,421	3,541	3,675	3,713	3,741	3,731
Total Liabilities	4,406	3,122	2,943	2,447	2,209	2,117	2,108	2,090	2,246	2,200	2,147
Total Current Liabilities	1,574	667	868	524	717	660	511	537	540	523	564
Short-Term Debt	520	18	300	19	193	131	21	27	19	20	25
Accounts Payable	397	237	197	224	238	223	182	210	229	194	219
Other Current Liabilities	657	412	371	281	286	305	308	301	292	310	320
Total Noncurrent Liabilities	2,833	2,455	2,074	1,923	1,492	1,458	1,598	1,554	1,707	1,677	1,583
Long-Term Debt	1,769	1,699	1,544	1,525	1,104	1,098	1,238	1,234	1,391	1,361	1,275
Noncurrent Deferred & Payable Income Tax Liabilities	471	336	255	182	176	101	103	129	140	136	133
Other Noncurrent Operating Liabilities	593	421	275	216	212	259	257	190	175	180	175
Total Equity & Noncontrolling Interests	2,522	1,864	1,829	1,742	1,745	1,304	1,433	1,584	1,467	1,541	1,584
Total Preferred & Common Equity	2,522	1,864	1,829	1,742	1,745	1,304	1,433	1,584	1,467	1,541	1,584
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,522	1,864	1,829	1,742	1,745	1,304	1,433	1,584	1,467	1,541	1,584
Common Stock	1,642	1,645	1,643	1,624	1,629	1,628	1,633	1,632	1,605	1,595	1,587
Retained Earnings	1,373	773	946	953	1,083	715	782	866	939	1,022	1,090
Treasury Stock	-222	-382	-563	-704	-819	-804	-790	-776	-861	-906	-938
Accumulated Other Comprehensive Income / (Loss)	-271	-172	-197	-131	-148	-236	-192	-137	-216	-170	-155

This table presents Edgewell Personal Care's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	3/31/2023	6/30/2023	12/31/2023	3/31/2024	6/30/2024	12/31/2024	3/31/2025	6/30/2025
Total Assets	3,721	3,799	3,766	3,787	3,756	3,708	3,702	3,773	3,793
Total Current Assets	934	1,009	989	1,006	995	959	945	1,012	1,005
Cash & Equivalents	182	155	207	214	196	196	176	170	200
Accounts Receivable	155	161	122	113	131	155	121	178	153
Inventories, net	414	541	503	522	496	456	502	512	488
Prepaid Expenses	183	153	157	157	172	152	148	152	164
Plant, Property, & Equipment, net	348	342	340	334	328	325	343	345	356
Total Noncurrent Assets	2,440	2,447	2,438	2,448	2,434	2,424	2,415	2,416	2,433
Goodwill	1,332	1,334	1,336	1,337	1,334	1,333	1,329	1,333	1,343
Intangible Assets	1,011	990	984	970	960	952	934	930	929
Other Noncurrent Operating Assets	97	123	118	141	140	139	152	153	161
Total Liabilities & Shareholders' Equity	3,721	3,799	3,766	3,787	3,756	3,708	3,702	3,773	3,793
Total Liabilities	2,243	2,292	2,215	2,241	2,205	2,132	2,201	2,259	2,225
Total Current Liabilities	575	569	580	468	542	535	459	536	567
Short-Term Debt	19	22	18	24	24	21	27	27	23
Accounts Payable	239	245	241	198	220	209	204	216	225
Other Current Liabilities	317	302	321	246	299	305	228	294	320
Total Noncurrent Liabilities	1,668	1,723	1,635	1,774	1,663	1,597	1,742	1,723	1,658
Long-Term Debt	1,357	1,414	1,323	1,452	1,351	1,290	1,441	1,433	1,373
Noncurrent Deferred & Payable Income Tax Liabilities	138	142	142	137	136	137	133	133	134
Other Noncurrent Operating Liabilities	173	167	170	185	176	169	169	157	152
Total Equity & Noncontrolling Interests	1,478	1,507	1,551	1,546	1,551	1,577	1,501	1,514	1,568
Total Preferred & Common Equity	1,478	1,507	1,551	1,546	1,551	1,577	1,501	1,514	1,568
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,478	1,507	1,551	1,546	1,551	1,577	1,501	1,514	1,568
Common Stock	1,601	1,584	1,587	1,570	1,575	1,582	1,563	1,568	1,574
Retained Earnings	906	946	991	1,019	1,048	1,089	1,081	1,102	1,124
Treasury Stock	-847	-864	-876	-897	-911	-921	-945	-979	-1,004
Accumulated Other Comprehensive Income / (Loss)	-182	-160	-151	-147	-160	-173	-198	-177	-127

This table displays calculated financial ratios and metrics derived from Edgewell Personal Care's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2014	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.67%	-7.31%	-2.45%	-2.69%	-2.78%	-4.18%	-8.94%	7.06%	4.04%	3.68%	0.09%
EBITDA Growth	-15.84%	-140.97%	333.90%	-71.19%	197.56%	2.03%	-21.60%	24.55%	-13.04%	11.28%	-10.14%
EBIT Growth	-20.24%	-205.59%	204.33%	-94.41%	1,322.09%	4.53%	-27.90%	38.01%	-18.91%	15.70%	-12.73%
NOPAT Growth	-16.61%	-165.00%	272.07%	-100.32%	17,717.17%	25.81%	-20.14%	40.97%	-23.92%	20.61%	-7.80%
Net Income Growth	-12.51%	-177.31%	164.91%	-96.81%	1,712.28%	-460.31%	118.16%	74.26%	-15.53%	15.28%	-14.04%
EPS Growth	-12.51%	-178.03%	167.34%	-96.66%	1,800.00%	-462.11%	118.02%	71.77%	-13.15%	19.46%	-10.86%
Operating Cash Flow Growth	-23.73%	-73.99%	25.54%	67.88%	-17.28%	-26.52%	22.04%	-1.55%	-55.46%	111.86%	6.90%
Free Cash Flow Firm Growth	142.49%	-49.59%	-74.30%	-13.32%	-4.05%	423.52%	-99.98%	83,297.14%	-215.19%	190.92%	19.63%
Invested Capital Growth	-23.37%	-22.10%	2.32%	-5.15%	-0.31%	-21.04%	6.21%	1.66%	13.65%	0.58%	-1.10%
Revenue Q/Q Growth	10.91%	107.47%	2.18%	-1.95%	-1.22%	-0.44%	-1.97%	2.68%	-0.29%	-0.12%	-0.73%
EBITDA Q/Q Growth	-2.81%	-658.84%	11,745.45%	-74.12%	505.51%	233.90%	-68.96%	7.01%	-0.38%	-3.08%	-9.80%
EBIT Q/Q Growth	-5.19%	-172.78%	409.33%	-95.12%	637.82%	170.35%	-76.97%	10.85%	-1.36%	-4.48%	-12.85%
NOPAT Q/Q Growth	6.93%	-94.24%	500.22%	-100.30%	400.45%	170.52%	-78.61%	15.83%	-9.15%	0.34%	-12.53%
Net Income Q/Q Growth	-5.29%	-1,036.39%	292.15%	-97.24%	260.16%	5.41%	-22.57%	25.45%	-9.38%	-3.94%	-17.63%
EPS Q/Q Growth	-5.29%	-1,044.68%	289.24%	-97.24%	259.66%	5.36%	-22.98%	25.29%	-7.96%	-3.07%	-16.88%
Operating Cash Flow Q/Q Growth	-13.19%	-31.43%	44.58%	-1.29%	-27.96%	8.23%	10.24%	-15.15%	-29.90%	9.20%	12.63%
Free Cash Flow Firm Q/Q Growth	522.59%	-41.89%	-71.81%	-41.01%	-31.34%	202.94%	-99.98%	381.44%	1.16%	-1.65%	8.04%
Invested Capital Q/Q Growth	-25.82%	-23.13%	-3.99%	-8.94%	-0.95%	-5.17%	10.18%	1.43%	0.62%	0.74%	-0.66%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.38%	48.89%	49.11%	48.99%	46.23%	45.15%	45.18%	45.57%	40.54%	41.78%	42.41%
EBITDA Margin	15.35%	-6.79%	16.27%	4.82%	14.74%	15.70%	13.51%	15.72%	13.14%	14.11%	12.66%
Operating Margin	10.17%	-8.22%	12.49%	-0.05%	9.63%	11.39%	9.03%	11.49%	8.39%	10.08%	8.84%
EBIT Margin	10.14%	-11.55%	12.35%	0.71%	10.37%	11.32%	8.96%	11.55%	9.00%	10.05%	8.76%
Profit (Net Income) Margin	13.63%	-11.37%	7.57%	0.25%	4.62%	-17.38%	3.47%	5.64%	4.58%	5.09%	4.38%
Tax Burden Percent	244.24%	60.02%	81.26%	-10.78%	63.06%	95.36%	77.43%	80.08%	80.18%	77.66%	81.56%
Interest Burden Percent	55.06%	164.06%	75.39%	-324.54%	70.66%	-161.08%	49.97%	61.01%	63.48%	65.30%	61.25%
Effective Tax Rate	19.27%	0.00%	18.74%	0.00%	36.94%	0.00%	22.57%	19.92%	19.82%	22.34%	18.45%
Return on Invested Capital (ROIC)	5.05%	-4.26%	8.27%	-0.03%	4.88%	6.87%	6.03%	8.19%	5.78%	6.54%	6.04%
ROIC Less NNEP Spread (ROIC-NNEP)	13.13%	-16.82%	2.47%	0.58%	1.76%	-49.73%	-1.68%	-0.68%	1.12%	1.37%	0.37%
Return on Net Nonoperating Assets (RNNOA)	9.26%	-8.30%	1.41%	0.35%	1.05%	-31.29%	-1.09%	-0.38%	0.74%	1.09%	0.27%
Return on Equity (ROE)	14.31%	-12.55%	9.68%	0.32%	5.93%	-24.42%	4.94%	7.81%	6.52%	7.63%	6.31%
Cash Return on Invested Capital (CROIC)	31.52%	20.59%	5.97%	5.25%	5.19%	30.39%	0.01%	6.54%	-7.00%	5.96%	7.15%
Operating Return on Assets (OROA)	3.88%	-4.69%	5.98%	0.36%	5.69%	6.57%	5.02%	6.68%	5.29%	6.07%	5.28%
Return on Assets (ROA)	5.22%	-4.62%	3.66%	0.13%	2.54%	-10.09%	1.94%	3.27%	2.69%	3.08%	2.64%
Return on Common Equity (ROCE)	14.31%	-12.55%	9.68%	0.32%	5.93%	-24.42%	4.94%	7.81%	6.52%	7.63%	6.31%
Return on Equity Simple (ROE_SIMPLE)	14.12%	-14.77%	9.77%	0.33%	5.92%	-28.55%	4.72%	7.44%	6.78%	7.45%	6.22%
Net Operating Profit after Tax (NOPAT)	214	-139	240	-0.77	136	171	136	192	146	176	163
NOPAT Margin	8.21%	-5.76%	10.15%	-0.03%	6.07%	7.97%	6.99%	9.20%	6.73%	7.83%	7.21%
Net Nonoperating Expense Percent (NNEP)	-8.07%	12.57%	5.79%	-0.60%	3.12%	56.60%	7.71%	8.87%	4.66%	5.16%	5.67%
Cost of Revenue to Revenue	50.62%	51.11%	50.89%	51.01%	53.77%	54.85%	54.82%	54.43%	59.46%	58.22%	57.59%
SG&A Expenses to Revenue	20.47%	23.61%	17.47%	17.08%	17.68%	0.00%	20.97%	18.74%	17.92%	18.19%	19.08%
R&D to Revenue	2.66%	2.93%	3.04%	2.94%	2.73%	2.50%	2.84%	2.77%	2.56%	2.60%	2.59%
Operating Expenses to Revenue	39.21%	57.12%	36.61%	49.03%	36.60%	16.38%	36.15%	34.08%	32.15%	31.70%	33.56%
Earnings before Interest and Taxes (EBIT)	265	-280	292	16	232	242	175	241	196	226	197
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	401	-164	384	111	329	336	264	328	285	318	285
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.81	2.57	2.42	2.24	1.35	1.27	1.00	1.19	1.28	1.20	1.13
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.72	1.98	1.87	1.70	1.05	0.77	0.73	0.91	0.87	0.82	0.80
Price to Earnings (P/E)	19.92	0.00	24.73	685.73	22.80	2.91	21.14	16.05	18.89	16.12	18.17
Dividend Yield	1.74%	48.29%	0.00%	0.00%	0.00%	0.00%	0.00%	1.72%	1.65%	1.65%	1.65%
Earnings Yield	5.02%	0.00%	4.04%	0.15%	4.39%	34.35%	4.73%	6.23%	5.29%	6.21%	5.50%
Enterprise Value to Invested Capital (EV/IC)	2.24	2.02	1.88	1.78	1.22	1.16	1.00	1.13	1.15	1.11	1.08
Enterprise Value to Revenue (EV/Rev)	3.16	2.39	2.34	2.15	1.52	1.19	1.19	1.28	1.43	1.34	1.28
Enterprise Value to EBITDA (EV/EBITDA)	20.58	0.00	14.38	44.72	10.28	7.58	8.82	8.14	10.87	9.48	10.10
Enterprise Value to EBIT (EV/EBIT)	31.17	0.00	18.94	303.72	14.61	10.51	13.30	11.08	15.86	13.32	14.60
Enterprise Value to NOPAT (EV/NOPAT)	38.49	0.00	23.04	0.00	24.96	14.92	17.05	13.91	21.22	17.09	17.73
Enterprise Value to Operating Cash Flow (EV/OCF)	14.43	38.90	29.58	15.79	13.05	13.36	9.99	11.67	30.41	13.94	12.48
Enterprise Value to Free Cash Flow (EV/FCFF)	6.17	8.59	31.88	32.95	23.49	3.37	12,619.88	17.41	0.00	18.74	14.99
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.91	0.92	1.01	0.89	0.74	0.94	0.88	0.80	0.96	0.90	0.82
Long-Term Debt to Equity	0.70	0.91	0.84	0.88	0.63	0.84	0.86	0.78	0.95	0.88	0.80
Financial Leverage	0.71	0.49	0.57	0.60	0.59	0.63	0.65	0.56	0.66	0.79	0.72
Leverage Ratio	2.74	2.72	2.64	2.51	2.34	2.42	2.54	2.39	2.42	2.48	2.39
Compound Leverage Factor	1.51	4.46	1.99	-8.14	1.65	-3.90	1.27	1.46	1.54	1.62	1.46
Debt to Total Capital	47.57%	47.93%	50.21%	47.00%	42.64%	48.53%	46.77%	44.31%	49.01%	47.26%	45.07%
Short-Term Debt to Total Capital	10.80%	0.49%	8.17%	0.59%	6.35%	5.19%	0.78%	0.93%	0.66%	0.67%	0.85%
Long-Term Debt to Total Capital	36.77%	47.44%	42.04%	46.41%	36.29%	43.35%	45.99%	43.38%	48.35%	46.59%	44.22%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	52.43%	52.07%	49.79%	53.00%	57.36%	51.47%	53.23%	55.69%	50.99%	52.74%	54.93%
Debt to EBITDA	5.71	-10.44	4.80	13.95	3.94	3.66	4.78	3.84	4.94	4.35	4.55
Net Debt to EBITDA	2.89	-6.11	2.88	9.41	3.13	2.64	3.39	2.38	4.28	3.66	3.82
Long-Term Debt to EBITDA	4.41	-10.34	4.02	13.78	3.35	3.27	4.70	3.76	4.88	4.28	4.47
Debt to NOPAT	10.67	-12.31	7.69	-2,006.23	9.56	7.20	9.24	6.56	9.65	7.83	8.00
Net Debt to NOPAT	5.41	-7.20	4.61	-1,353.12	7.60	5.20	6.56	4.07	8.36	6.60	6.71
Long-Term Debt to NOPAT	8.25	-12.19	6.44	-1,981.04	8.14	6.43	9.08	6.42	9.52	7.72	7.84
Altman Z-Score	1.95	1.67	2.02	2.03	1.85	1.76	1.59	1.85	1.75	1.83	1.81
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.73	2.45	1.67	2.26	1.33	1.58	1.93	2.12	1.75	1.84	1.66
Quick Ratio	1.03	1.49	1.15	1.39	0.69	0.83	1.03	1.17	0.60	0.62	0.57
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,337	674	173	150	144	755	0.18	154	-177	161	192
Operating Cash Flow to CapEx	750.66%	179.71%	268.78%	619.76%	452.71%	353.62%	0.00%	464.50%	198.44%	436.57%	408.85%
Free Cash Flow to Firm to Interest Expense	11.24	6.76	2.41	2.17	2.12	12.06	0.00	1.63	-2.48	2.05	2.51
Operating Cash Flow to Interest Expense	4.81	1.49	2.60	4.53	3.81	3.04	2.66	2.44	1.43	2.75	3.02
Operating Cash Flow Less CapEx to Interest Expense	4.17	0.66	1.63	3.80	2.97	2.18	3.21	1.91	0.71	2.12	2.28
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.38	0.41	0.48	0.51	0.55	0.58	0.56	0.58	0.59	0.60	0.60
Accounts Receivable Turnover	5.36	6.25	8.74	9.48	9.92	9.91	10.70	13.49	15.10	18.52	20.91
Inventory Turnover	2.14	2.61	3.74	3.65	3.62	3.42	3.18	3.44	3.25	2.78	2.68
Fixed Asset Turnover	3.47	3.87	4.80	4.89	5.09	5.22	5.08	5.69	6.13	6.59	6.56
Accounts Payable Turnover	3.59	3.90	5.55	5.58	5.20	5.09	5.28	5.81	5.89	6.19	6.28
Days Sales Outstanding (DSO)	68.16	58.40	41.76	38.49	36.80	36.83	34.11	27.06	24.17	19.70	17.46
Days Inventory Outstanding (DIO)	170.20	140.07	97.47	100.04	100.71	106.71	114.63	105.99	112.37	131.11	136.34
Days Payable Outstanding (DPO)	101.79	93.51	65.80	65.39	70.17	71.67	69.10	62.87	61.95	58.92	58.17
Cash Conversion Cycle (CCC)	136.57	104.96	73.43	73.14	67.33	71.87	79.63	70.18	74.59	91.89	95.63
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,682	2,868	2,935	2,784	2,775	2,191	2,327	2,366	2,689	2,704	2,675
Invested Capital Turnover	0.62	0.74	0.81	0.80	0.80	0.86	0.86	0.89	0.86	0.84	0.84
Increase / (Decrease) in Invested Capital	-1,123	-814	67	-151	-8.50	-584	136	39	323	16	-30
Enterprise Value (EV)	8,254	5,789	5,525	4,951	3,386	2,547	2,323	2,673	3,102	3,012	2,882
Market Capitalization	7,094	4,785	4,420	3,909	2,355	1,659	1,429	1,891	1,880	1,848	1,792
Book Value per Share	$40.84	$29.97	$31.03	$30.57	$32.28	$24.07	$26.36	$29.14	$28.31	$30.32	$32.13
Tangible Book Value per Share	($13.15)	($15.54)	($16.56)	($13.62)	($14.90)	($11.86)	($12.05)	($8.92)	($16.43)	($15.05)	($14.26)
Total Capital	4,811	3,580	3,674	3,287	3,042	2,533	2,692	2,845	2,878	2,921	2,884
Total Debt	2,288	1,716	1,845	1,545	1,297	1,229	1,259	1,261	1,410	1,380	1,300
Total Long-Term Debt	1,769	1,699	1,544	1,525	1,104	1,098	1,238	1,234	1,391	1,361	1,275
Net Debt	1,159	1,004	1,106	1,042	1,031	888	894	782	1,222	1,164	1,090
Capital Expenditures (CapEx)	76	83	70	51	57	54	-48	49	51	50	57
Debt-free, Cash-free Net Working Capital (DFCFNWC)	546	275	145	178	161	175	130	146	233	242	188
Debt-free Net Working Capital (DFNWC)	1,675	987	884	681	427	516	494	625	422	459	397
Net Working Capital (NWC)	1,156	970	584	662	234	385	473	599	403	439	372
Net Nonoperating Expense (NNE)	-142	136	61	-6.47	32	543	69	74	47	62	64
Net Nonoperating Obligations (NNO)	1,159	1,004	1,106	1,042	1,031	888	894	782	1,222	1,164	1,090
Total Depreciation and Amortization (D&A)	136	115	93	94	98	94	89	87	90	91	88
Debt-free, Cash-free Net Working Capital to Revenue	20.92%	11.37%	6.15%	7.76%	7.20%	8.16%	6.64%	7.00%	10.73%	10.75%	8.33%
Debt-free Net Working Capital to Revenue	64.14%	40.78%	37.43%	29.64%	19.12%	24.11%	25.35%	29.96%	19.42%	20.36%	17.61%
Net Working Capital to Revenue	44.25%	40.05%	24.72%	28.79%	10.48%	17.97%	24.27%	28.69%	18.54%	19.50%	16.52%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.26	($4.44)	$3.02	$0.10	$1.90	($6.88)	$1.25	$2.15	$1.86	$2.24	$1.98
Adjusted Weighted Average Basic Shares Outstanding	83.65M	60.03M	57.91M	56.02M	54.04M	54.21M	54.36M	54.37M	51.44M	50.02M	48.72M
Adjusted Diluted Earnings per Share	$4.22	($4.44)	$2.99	$0.10	$1.90	($6.88)	$1.24	$2.12	$1.84	$2.21	$1.97
Adjusted Weighted Average Diluted Shares Outstanding	83.65M	60.03M	57.91M	56.02M	54.04M	54.21M	54.36M	54.37M	51.44M	50.02M	48.72M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	83.65M	60.03M	57.91M	56.02M	54.04M	54.21M	54.36M	54.37M	51.44M	50.02M	48.72M
Normalized Net Operating Profit after Tax (NOPAT)	254	122	275	243	179	203	155	209	158	189	192
Normalized NOPAT Margin	9.72%	5.03%	11.65%	10.58%	8.00%	9.49%	7.97%	10.00%	7.30%	8.40%	8.51%
Pre Tax Income Margin	5.58%	-18.95%	9.31%	-2.30%	7.33%	-18.23%	4.48%	7.05%	5.71%	6.56%	5.36%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.23	-2.80	4.06	0.24	3.41	3.87	2.00	2.56	2.74	2.88	2.58
NOPAT to Interest Expense	1.80	-1.40	3.34	-0.01	1.99	2.73	1.56	2.04	2.05	2.25	2.12
EBIT Less CapEx to Interest Expense	1.58	-3.63	3.09	-0.50	2.57	3.01	2.55	2.04	2.02	2.25	1.84
NOPAT Less CapEx to Interest Expense	1.16	-2.23	2.37	-0.74	1.15	1.87	2.11	1.52	1.33	1.62	1.39
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	34.79%	-33.85%	0.00%	0.00%	0.00%	0.00%	0.00%	21.73%	32.76%	27.46%	31.14%
Augmented Payout Ratio	61.30%	-97.49%	110.02%	2,901.75%	120.43%	0.00%	0.00%	29.54%	158.69%	93.03%	90.47%

This table displays calculated financial ratios and metrics derived from Edgewell Personal Care's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.25%	9.26%	4.20%	-0.52%	4.22%	0.17%	-0.34%	-3.09%	-2.15%	-3.12%	-3.18%
EBITDA Growth	8.20%	3.07%	46.48%	-11.83%	-18.69%	27.56%	-8.44%	-41.17%	-19.67%	-7.24%	-23.59%
EBIT Growth	10.15%	4.88%	65.75%	-16.93%	-30.08%	42.49%	-9.67%	-55.96%	-33.72%	-8.75%	-30.38%
NOPAT Growth	5.84%	16.04%	53.91%	2.15%	-10.26%	29.61%	0.48%	-28.94%	-31.94%	-22.97%	-35.21%
Net Income Growth	10.71%	-16.38%	73.77%	-13.58%	-61.29%	85.57%	-7.55%	-70.57%	-143.75%	-19.44%	-40.61%
EPS Growth	20.00%	-13.95%	78.95%	-10.77%	-62.50%	94.59%	-3.92%	-68.97%	-144.44%	-16.67%	-36.73%
Operating Cash Flow Growth	-9.24%	125.58%	48.17%	61.49%	15.53%	46.26%	-39.18%	54.18%	-58.57%	-65.04%	13.44%
Free Cash Flow Firm Growth	102.95%	1,059.98%	117.57%	111.28%	-103.57%	-195.26%	9.00%	101.55%	9,165.63%	98.76%	-152.58%
Invested Capital Growth	0.52%	0.00%	0.46%	0.58%	0.76%	0.00%	0.29%	-1.10%	-0.53%	2.73%	2.67%
Revenue Q/Q Growth	-12.63%	27.56%	8.62%	-17.83%	-8.46%	22.60%	8.07%	-20.10%	-7.57%	21.38%	8.01%
EBITDA Q/Q Growth	-30.45%	18.52%	59.80%	-33.07%	-35.86%	85.92%	14.70%	-56.99%	-12.42%	114.69%	-5.52%
EBIT Q/Q Growth	-41.05%	28.18%	90.27%	-42.22%	-50.38%	161.24%	20.62%	-71.83%	-25.33%	259.65%	-7.97%
NOPAT Q/Q Growth	-49.19%	78.03%	55.77%	-27.50%	-55.37%	157.15%	20.75%	-48.73%	-57.26%	191.05%	1.57%
Net Income Q/Q Growth	-64.16%	56.45%	173.20%	-43.58%	-83.95%	650.00%	36.11%	-82.04%	-123.86%	1,480.95%	0.34%
EPS Q/Q Growth	-63.08%	54.17%	175.68%	-43.14%	-84.48%	700.00%	36.11%	-81.63%	-122.22%	1,600.00%	3.33%
Operating Cash Flow Q/Q Growth	-391.55%	202.20%	88.66%	-71.27%	-252.51%	276.95%	-21.55%	-27.17%	-256.85%	139.01%	154.55%
Free Cash Flow Firm Q/Q Growth	103.24%	31,220.83%	-98.14%	-40.22%	-101.02%	-836,089.49%	102.13%	10.53%	-53.98%	-214.59%	9.77%
Invested Capital Q/Q Growth	3.65%	-100.00%	0.00%	0.74%	3.84%	-2.80%	-1.36%	-0.66%	4.44%	0.39%	-1.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	40.42%	40.49%	43.12%	42.80%	40.44%	43.06%	44.32%	41.11%	40.05%	44.12%	42.81%
EBITDA Margin	12.66%	11.76%	17.31%	14.10%	9.88%	14.98%	15.90%	8.56%	8.11%	14.34%	12.55%
Operating Margin	6.80%	9.49%	13.26%	9.75%	5.34%	11.70%	12.77%	3.94%	4.24%	10.14%	8.56%
EBIT Margin	7.87%	7.90%	13.85%	9.74%	5.28%	11.24%	12.55%	4.42%	3.57%	10.59%	9.02%
Profit (Net Income) Margin	2.64%	3.24%	8.15%	5.60%	0.98%	6.01%	7.56%	1.70%	-0.44%	4.99%	4.64%
Tax Burden Percent	72.94%	72.93%	74.86%	89.79%	80.00%	76.60%	78.40%	162.96%	123.53%	70.22%	78.23%
Interest Burden Percent	46.07%	56.24%	78.67%	64.04%	23.26%	69.73%	76.88%	23.58%	-9.94%	67.15%	65.72%
Effective Tax Rate	27.06%	27.07%	25.14%	10.21%	20.00%	23.40%	21.60%	-62.96%	0.00%	29.78%	21.77%
Return on Invested Capital (ROIC)	3.89%	0.00%	8.36%	7.31%	3.47%	14.92%	8.45%	5.38%	2.38%	5.73%	5.41%
ROIC Less NNEP Spread (ROIC-NNEP)	3.02%	0.00%	7.37%	5.90%	2.20%	11.91%	7.04%	3.21%	1.10%	4.72%	4.29%
Return on Net Nonoperating Assets (RNNOA)	2.46%	0.00%	5.66%	4.68%	1.83%	9.05%	5.07%	2.32%	0.92%	3.80%	3.16%
Return on Equity (ROE)	6.35%	0.00%	14.02%	11.99%	5.30%	23.96%	13.52%	7.70%	3.30%	9.53%	8.57%
Cash Return on Invested Capital (CROIC)	4.78%	0.00%	6.10%	5.96%	5.44%	-186.47%	6.62%	7.15%	6.13%	2.50%	1.79%
Operating Return on Assets (OROA)	4.50%	0.00%	8.34%	5.88%	3.16%	6.80%	7.62%	2.67%	2.14%	6.26%	5.30%
Return on Assets (ROA)	1.51%	0.00%	4.91%	3.38%	0.59%	3.63%	4.59%	1.03%	-0.26%	2.95%	2.73%
Return on Common Equity (ROCE)	6.35%	0.00%	14.02%	11.99%	5.30%	23.96%	13.52%	7.70%	3.30%	9.53%	8.57%
Return on Equity Simple (ROE_SIMPLE)	6.68%	0.00%	7.70%	0.00%	6.93%	7.97%	7.59%	0.00%	6.11%	5.59%	0.00%
Net Operating Profit after Tax (NOPAT)	23	41	65	47	21	54	65	33	14	41	42
NOPAT Margin	4.96%	6.92%	9.93%	8.76%	4.27%	8.96%	10.01%	6.42%	2.97%	7.12%	6.70%
Net Nonoperating Expense Percent (NNEP)	0.87%	0.00%	0.99%	1.42%	1.27%	3.00%	1.41%	2.17%	1.28%	1.00%	1.12%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	0.69%	-	-	-	0.48%	1.39%	1.42%
Cost of Revenue to Revenue	59.58%	59.51%	56.88%	57.20%	59.56%	56.94%	55.68%	58.89%	59.95%	55.88%	57.19%
SG&A Expenses to Revenue	20.40%	17.58%	14.82%	21.04%	21.13%	17.93%	17.00%	21.10%	21.51%	18.20%	16.65%
R&D to Revenue	2.86%	2.41%	2.28%	2.98%	2.72%	2.37%	2.25%	3.15%	2.91%	2.39%	2.23%
Operating Expenses to Revenue	33.62%	31.00%	29.86%	33.05%	35.10%	31.36%	31.55%	37.17%	35.81%	33.98%	34.25%
Earnings before Interest and Taxes (EBIT)	37	47	90	52	26	67	81	23	17	62	57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	59	70	113	75	48	90	103	44	39	83	79
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.29	0.00	1.34	1.20	1.19	1.24	1.26	1.13	1.12	0.99	0.70
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.89	0.96	0.92	0.82	0.81	0.85	0.88	0.80	0.75	0.68	0.50
Price to Earnings (P/E)	19.24	22.07	17.42	16.12	17.11	15.54	16.64	18.17	18.36	17.77	16.99
Dividend Yield	1.59%	1.44%	1.48%	1.65%	1.66%	1.56%	1.49%	1.65%	1.79%	1.92%	2.56%
Earnings Yield	5.20%	4.53%	5.74%	6.21%	5.84%	6.44%	6.01%	5.50%	5.45%	5.63%	5.89%
Enterprise Value to Invested Capital (EV/IC)	1.15	0.00	1.20	1.11	1.10	1.14	1.15	1.08	1.07	1.00	0.83
Enterprise Value to Revenue (EV/Rev)	1.48	0.00	1.43	1.34	1.36	1.36	1.37	1.28	1.33	1.26	1.04
Enterprise Value to EBITDA (EV/EBITDA)	11.10	0.00	9.81	9.48	10.10	9.51	9.82	10.10	10.79	10.38	9.37
Enterprise Value to EBIT (EV/EBIT)	16.17	0.00	13.57	13.32	14.39	13.18	13.72	14.60	15.77	15.29	14.53
Enterprise Value to NOPAT (EV/NOPAT)	21.88	0.00	18.29	17.09	17.86	16.79	16.72	17.73	18.99	19.46	19.01
Enterprise Value to Operating Cash Flow (EV/OCF)	33.97	0.00	16.24	13.94	13.48	11.47	15.15	12.48	15.81	26.78	19.47
Enterprise Value to Free Cash Flow (EV/FCFF)	24.23	0.00	19.66	18.74	20.35	0.00	17.45	14.99	17.35	40.49	47.03
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.95	0.00	0.86	0.90	0.96	0.89	0.83	0.82	0.98	0.96	0.89
Long-Term Debt to Equity	0.94	0.00	0.85	0.88	0.94	0.87	0.82	0.80	0.96	0.95	0.88
Financial Leverage	0.82	0.00	0.77	0.79	0.83	0.76	0.72	0.72	0.84	0.81	0.74
Leverage Ratio	2.49	0.00	2.47	2.48	2.48	2.42	2.39	2.39	2.46	2.46	2.39
Compound Leverage Factor	1.15	0.00	1.94	1.59	0.58	1.69	1.84	0.56	-0.24	1.65	1.57
Debt to Total Capital	48.78%	0.00%	46.36%	47.26%	48.85%	46.98%	45.42%	45.07%	49.44%	49.10%	47.10%
Short-Term Debt to Total Capital	0.73%	0.00%	0.61%	0.67%	0.80%	0.81%	0.74%	0.85%	0.92%	0.91%	0.78%
Long-Term Debt to Total Capital	48.05%	0.00%	45.75%	46.59%	48.05%	46.17%	44.68%	44.22%	48.52%	48.18%	46.31%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	51.22%	0.00%	53.64%	52.74%	51.15%	53.02%	54.58%	54.93%	50.56%	50.90%	52.90%
Debt to EBITDA	4.95	0.00	4.09	4.35	4.82	4.22	4.15	4.55	5.32	5.42	5.70
Net Debt to EBITDA	4.42	0.00	3.46	3.66	4.12	3.62	3.53	3.82	4.68	4.79	4.88
Long-Term Debt to EBITDA	4.88	0.00	4.04	4.28	4.74	4.14	4.08	4.47	5.22	5.32	5.60
Debt to NOPAT	9.76	0.00	7.63	7.83	8.52	7.44	7.06	8.00	9.36	10.17	11.55
Net Debt to NOPAT	8.70	0.00	6.45	6.60	7.28	6.38	6.00	6.71	8.24	8.98	9.90
Long-Term Debt to NOPAT	9.61	0.00	7.53	7.72	8.38	7.32	6.94	7.84	9.19	9.98	11.36
Altman Z-Score	1.60	0.00	1.74	1.68	1.66	1.72	1.79	1.65	1.65	1.60	1.48
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.77	0.00	1.71	1.84	2.15	1.84	1.79	1.66	2.06	1.89	1.77
Quick Ratio	0.56	0.00	0.57	0.62	0.70	0.60	0.66	0.57	0.64	0.65	0.62
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	8.97	2,809	52	31	-0.32	-2,676	57	63	29	-33	-30
Operating Cash Flow to CapEx	-763.72%	1,176.00%	1,352.85%	259.78%	-1,121.54%	1,121.74%	803.17%	284.56%	-688.10%	263.74%	740.65%
Free Cash Flow to Firm to Interest Expense	0.45	135.70	2.73	1.67	-0.02	-131.17	3.03	3.60	1.54	-1.65	-1.55
Operating Cash Flow to Interest Expense	-4.34	4.26	8.67	2.56	-3.68	6.32	5.38	4.21	-6.15	2.23	5.92
Operating Cash Flow Less CapEx to Interest Expense	-4.90	3.90	8.03	1.57	-4.01	5.76	4.71	2.73	-7.04	1.39	5.12
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.57	0.00	0.60	0.60	0.60	0.61	0.61	0.60	0.60	0.59	0.59
Accounts Receivable Turnover	13.82	0.00	16.29	18.52	16.62	17.40	16.42	20.91	19.25	14.41	14.30
Inventory Turnover	2.74	0.00	2.89	2.78	2.49	2.63	2.71	2.68	2.53	2.53	2.70
Fixed Asset Turnover	6.23	0.00	6.56	6.59	6.72	6.94	6.83	6.56	6.63	6.62	6.47
Accounts Payable Turnover	5.61	0.00	5.51	6.19	5.98	5.95	5.77	6.28	6.45	5.87	5.89
Days Sales Outstanding (DSO)	26.42	0.00	22.40	19.70	21.96	20.98	22.23	17.46	18.96	25.33	25.52
Days Inventory Outstanding (DIO)	133.36	0.00	126.51	131.11	146.61	138.55	134.68	136.34	144.39	144.16	135.19
Days Payable Outstanding (DPO)	65.12	0.00	66.29	58.92	61.08	61.32	63.21	58.17	56.62	62.22	62.02
Cash Conversion Cycle (CCC)	94.66	0.00	82.62	91.89	107.49	98.21	93.70	95.63	106.74	107.28	98.69
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,787	0.00	2,685	2,704	2,808	2,730	2,692	2,675	2,793	2,804	2,764
Invested Capital Turnover	0.78	0.00	0.84	0.84	0.81	1.67	0.84	0.84	0.80	0.80	0.81
Increase / (Decrease) in Invested Capital	14	-2,768	12	16	21	2,730	7.80	-30	-15	75	72
Enterprise Value (EV)	3,217	0.00	3,214	3,012	3,095	3,100	3,107	2,882	2,976	2,795	2,297
Market Capitalization	1,937	2,139	2,080	1,848	1,832	1,922	1,992	1,792	1,684	1,505	1,101
Book Value per Share	$29.29	$0.00	$30.31	$30.32	$30.85	$31.07	$31.82	$32.13	$30.82	$31.39	$33.34
Tangible Book Value per Share	($15.88)	$0.00	($15.02)	($15.05)	($15.20)	($14.88)	($14.30)	($14.26)	($15.65)	($15.53)	($14.97)
Total Capital	2,942	0.00	2,892	2,921	3,022	2,926	2,888	2,884	2,969	2,974	2,964
Total Debt	1,435	0.00	1,341	1,380	1,477	1,374	1,312	1,300	1,468	1,460	1,396
Total Long-Term Debt	1,414	0.00	1,323	1,361	1,452	1,351	1,290	1,275	1,441	1,433	1,373
Net Debt	1,280	0.00	1,133	1,164	1,262	1,178	1,116	1,090	1,292	1,290	1,196
Capital Expenditures (CapEx)	11	7.50	12	18	6.50	12	13	26	17	17	16
Debt-free, Cash-free Net Working Capital (DFCFNWC)	307	0.00	219	242	348	280	249	188	338	333	261
Debt-free Net Working Capital (DFNWC)	462	0.00	427	459	562	477	445	397	513	503	461
Net Working Capital (NWC)	440	0.00	409	439	538	453	424	372	486	476	437
Net Nonoperating Expense (NNE)	11	22	12	17	16	18	16	24	16	12	13
Net Nonoperating Obligations (NNO)	1,280	0.00	1,133	1,164	1,262	1,178	1,116	1,090	1,292	1,290	1,196
Total Depreciation and Amortization (D&A)	23	23	23	23	23	22	22	21	22	22	22
Debt-free, Cash-free Net Working Capital to Revenue	14.08%	0.00%	9.72%	10.75%	15.31%	12.34%	10.96%	8.33%	15.06%	14.98%	11.84%
Debt-free Net Working Capital to Revenue	21.20%	0.00%	18.92%	20.36%	24.74%	20.97%	19.60%	17.61%	22.89%	22.63%	20.89%
Net Working Capital to Revenue	20.22%	0.00%	18.13%	19.50%	23.68%	19.93%	18.66%	16.52%	21.67%	21.40%	19.84%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$1.03	$0.58	$0.10	$0.72	$0.99	$0.17	($0.04)	$0.60	$0.62
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	50.81M	50.02M	49.93M	49.55M	49.31M	48.72M	48.70M	48M	46.80M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$1.01	$0.58	$0.09	$0.72	$0.98	$0.18	($0.04)	$0.60	$0.62
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	50.81M	50.02M	49.93M	49.55M	49.31M	48.72M	48.70M	48.20M	47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	50.81M	50.02M	49.93M	49.55M	49.31M	48.72M	48.23M	47.03M	46.46M
Normalized Net Operating Profit after Tax (NOPAT)	25	44	67	54	26	56	67	30	17	50	55
Normalized NOPAT Margin	5.38%	7.29%	10.27%	10.09%	5.38%	9.37%	10.38%	5.84%	3.58%	8.60%	8.69%
Pre Tax Income Margin	3.62%	4.45%	10.89%	6.23%	1.23%	7.84%	9.65%	1.04%	-0.36%	7.11%	5.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.85	2.29	4.69	2.78	1.30	3.30	4.32	1.31	0.91	3.04	2.92
NOPAT to Interest Expense	1.17	2.00	3.36	2.50	1.05	2.63	3.45	1.90	0.76	2.05	2.17
EBIT Less CapEx to Interest Expense	1.29	1.92	4.05	1.80	0.97	2.74	3.65	-0.17	0.02	2.20	2.12
NOPAT Less CapEx to Interest Expense	0.60	1.64	2.72	1.52	0.73	2.07	2.78	0.42	-0.14	1.20	1.37
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	32.17%	33.02%	26.55%	27.46%	28.76%	25.22%	25.90%	31.14%	33.81%	35.54%	45.99%
Augmented Payout Ratio	147.17%	115.48%	77.14%	93.03%	98.97%	86.26%	84.54%	90.47%	114.29%	146.40%	213.43%

Financials Breakdown Chart

Key Financial Trends

Edgewell Personal Care (NYSE:EPC) Financial Highlights and Trends (2022 - Q3 2025)

Edgewell Personal Care has shown a series of financial trends in its recent quarterly reports spanning from 2022 through Q3 2025. Here’s a concise analysis for retail investors looking to understand their performance trajectory and balance sheet health.

Consistent Revenue Growth: Operating revenues steadily increased from approximately $469 million in Q1 2023 to $627 million by Q3 2025, indicating healthy sales expansion.
Improved Profitability: Net income rose significantly from $12.4 million in Q1 2023 to $29.1 million by Q3 2025, with operating income showing recovery after earlier dips.
Strong Operating Cash Flow: Net cash from continuing operating activities grew robustly, reaching $114.8 million in Q3 2025, highlighting efficient operations generating cash.
Stable Gross Margins: Gross profit margins remained relatively steady around 42-43%, reflecting solid cost control relative to revenue.
Dividend Payments Steady: Dividend payouts have been consistently maintained at around $0.15 per share quarterly, supporting shareholder returns.
Capital Expenditures: Investments in property, plant, and equipment ranged from $6.5 million to $25.9 million quarterly, indicating ongoing reinvestment in operational infrastructure.
Debt Management Activity: Edgewell actively repays and issues debt; net effects fluctuate quarter to quarter with sizable repayments and issuances, but long-term debt remains high around $1.37 billion in Q3 2025.
Shares Outstanding: Weighted average diluted shares outstanding gradually declined from ~51 million in early 2023 to ~47 million in Q3 2025, indicating modest share repurchases.
High Restructuring Charges: Substantial restructuring expenses have been reported quarterly, reaching up to $22.8 million in Q4 2024 and $16 million in Q3 2025, impacting profitability.
Increasing Liabilities: Total liabilities increased from about $2.24 billion in Q1 2023 to over $2.22 billion in Q3 2025, primarily driven by high long-term debt balances, potentially increasing financial risk.

Summary: Edgewell Personal Care demonstrates solid revenue and profit growth over recent quarters while generating strong operating cash flows. The company maintains steady dividends and continues to reinvest in its operations. However, high restructuring costs and elevated debt levels require close monitoring. Share repurchases coupled with earnings improvements reflect management's focus on shareholder value.

09/19/25 02:04 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Edgewell Personal Care's Financials

When does Edgewell Personal Care's financial year end?

According to the most recent income statement we have on file, Edgewell Personal Care's fiscal year ends in September. Their fiscal year 2024 ended on September 30, 2024.

How has Edgewell Personal Care's net income changed over the last 10 years?

Edgewell Personal Care's net income appears to be on an upward trend, with a most recent value of $98.60 million in 2024, falling from $356.10 million in 2014. The previous period was $114.70 million in 2023. See where experts think Edgewell Personal Care is headed by visiting Edgewell Personal Care's forecast page.

What is Edgewell Personal Care's operating income?

Edgewell Personal Care's total operating income in 2024 was $199.30 million, based on the following breakdown:

Total Gross Profit: $955.70 million
Total Operating Expenses: $756.40 million

How has Edgewell Personal Care's revenue changed over the last 10 years?

Over the last 10 years, Edgewell Personal Care's total revenue changed from $2.61 billion in 2014 to $2.25 billion in 2024, a change of -13.7%.

How much debt does Edgewell Personal Care have?

Edgewell Personal Care's total liabilities were at $2.15 billion at the end of 2024, a 2.4% decrease from 2023, and a 51.3% decrease since 2014.

How much cash does Edgewell Personal Care have?

In the past 10 years, Edgewell Personal Care's cash and equivalents has ranged from $188.70 million in 2022 to $1.13 billion in 2014, and is currently $209.10 million as of their latest financial filing in 2024.

How has Edgewell Personal Care's book value per share changed over the last 10 years?

Over the last 10 years, Edgewell Personal Care's book value per share changed from 40.84 in 2014 to 32.13 in 2024, a change of -21.3%.

Related Companies

This page (NYSE:EPC) was last updated on 9/19/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Edgewell Personal Care (EPC) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Edgewell Personal Care's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Edgewell Personal Care (EPC) Financials

Annual Income Statements for Edgewell Personal Care

Quarterly Income Statements for Edgewell Personal Care

Annual Cash Flow Statements for Edgewell Personal Care

Quarterly Cash Flow Statements for Edgewell Personal Care

Annual Balance Sheets for Edgewell Personal Care

Quarterly Balance Sheets for Edgewell Personal Care

Annual Metrics And Ratios for Edgewell Personal Care

Quarterly Metrics And Ratios for Edgewell Personal Care

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Edgewell Personal Care's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools